Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Pharmacol Ther ; 76(5): 480-9, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15536462

RESUMO

BACKGROUND: St John's wort (Hypericum perforatum) is a popular over-the-counter antidepressant. Its antidepressive effect has been attributed in part to inhibition of monoamine transporters and monoamine oxidase, on the basis of in vitro studies. METHODS: In a double-blind, randomized, placebo-controlled, crossover study, 16 healthy subjects (11 men and 5 women; mean age, 31 +/- 5 years) ingested either St John's wort (300 mg three times daily) or placebo for 7 days. Imipramine treatment (50 mg three times daily) in 7 subjects served as a positive control. After treatment, physiologic and biochemical tests included cardiovascular reflex testing, graded head-up tilt testing, and plasma catecholamine determinations. RESULTS: St John's wort had no effect on blood pressure, heart rate, heart rate variability, or blood pressure variability, regardless of the test condition. St John's wort had no effect on plasma concentrations of norepinephrine and its main metabolite, dihydroxyphenylglycol, whereas plasma dihydroxyphenylacetic acid (DOPAC; the main metabolite of dopamine) concentrations increased in every subject (1661 +/- 924 pg/mL versus 1110 +/- 322 pg/mL with placebo, P=.04). In contrast, imipramine increased resting blood pressure (124 +/- 10 mmHg/71 +/- 5 mmHg versus 110 +/- 8 mmHg/61 +/- 6 mmHg with placebo, P=.005 for systolic values and P=.003 for diastolic values) and heart rate (74 +/- 7 beats/min versus 62 +/- 6 beats/min with placebo, P=.005) and elicited a marked orthostatic tachycardia (increase in heart rate of 43 +/- 17 beats/min versus 26 +/- 8 beats/min with placebo, P=.006). CONCLUSIONS: Our findings challenge the concept that St John's wort elicits a major change in norepinephrine uptake or monoamine oxidase activity in vivo. The consistent increase in plasma DOPAC concentrations might suggest a novel mode of action or an inhibitory effect on dopamine beta-hydroxylase that should be followed up. We propose that a combination of physiologic and biochemical profiling may help better define the mode of action and potential side effects of herbal remedies.


Assuntos
Fenômenos Fisiológicos Cardiovasculares/efeitos dos fármacos , Catecolaminas/metabolismo , Hypericum , Metoxi-Hidroxifenilglicol/análogos & derivados , Perileno/análogos & derivados , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Inibidores da Captação Adrenérgica/farmacologia , Adulto , Antracenos , Sistema Nervoso Autônomo/efeitos dos fármacos , Catecolaminas/sangue , Estudos Cross-Over , Método Duplo-Cego , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Imipramina/farmacocinética , Imipramina/farmacologia , Masculino , Metoxi-Hidroxifenilglicol/metabolismo , Doadores de Óxido Nítrico/farmacologia , Nitroprussiato/farmacologia , Norepinefrina/metabolismo , Perileno/sangue , Postura/fisiologia , Decúbito Dorsal/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA